U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07005050) titled 'Renal Pelvic Denervation Pilot Trial' on May 26.
Brief Summary: The RPD Pilot trial will evaluate the safety and effectiveness of Verve Medical's RPDTM renal denervation system for hypertensive patients with uncontrolled blood pressure despite use of two medications at a therapeutic dose.
The novelty of the RPDTM system relates to its placement via natural orifice into the renal pelvis (bilaterally) for delivery of radiofrequency energy to ablate the nerves that pass through the outer wall of the renal pelvis, a technique referred to as renal pelvic denervation (RPD).
Study Start Date: July 30
Study Type: INTERVENTIONAL
Condition...